401k Plan data: CENTROME, INC. D/B/A ADVANCED BIOTECH CASH BALANCE PENSION TRUST plan

CENTROME, INC. D/B/A ADVANCED BIOTECH CASH BALANCE PENSION TRUST 401k Plan overview

Plan Name	CENTROME, INC. D/B/A ADVANCED BIOTECH CASH BALANCE PENSION TRUST
Plan identification number	003

CENTROME, INC. D/B/A ADVANCED BIOTECH CASH BALANCE PENSION TRUST Benefits

401k Plan Type

Defined Benefit Pension

Plan Features/Benefits

Benefits are primarily pay related
Cash balance or similar plan - Plan has a "cash balance" formula. For this purpose, a "cash balance" formula is a benefit formula in a defined benefit plan by whatever name (for example, personal account plan, pension equity plan, life cycle plan, cash account plan, etc.) that rather than, or in addition to, expressing the accrued benefit as a life annuity commencing at normal retirement age, defines benefits for each employee in terms more common to a defined contribution plan such as a single sum distribution amount (for example, 10 percent of final average pay times years of service, or the amount of the employee's hypothetical account balance).
Covered by PBGC - Plan is covered under the PBGC insurance program (see ERISA section 4021).
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.

401k Sponsoring company profile

CENTROME, INC. D/B/A ADVANCED BIOTECH has sponsored the creation of one or more 401k plans.

Company Name: CENTROME, INC. D/B/A ADVANCED BIOTECH

Employer identification number (EIN): 223253350

NAIC Classification: 423990
NAIC Description: Other Miscellaneous Durable Goods Merchant Wholesalers

Form 5500 Filing Information

Submission information for form 5500 for 401k plan CENTROME, INC. D/B/A ADVANCED BIOTECH CASH BALANCE PENSION TRUST

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
003 2024-01-01 MARYLOU FIGUERA
003 2023-01-01
003 2023-01-01 JAMES MULLIGAN
003 2021-01-01 JAMES MULLIGAN 2022-10-13
003 2020-01-01 JAMES MULLIGAN 2021-10-01
003 2019-01-01 JAMES MULLIGAN 2020-07-08
003 2018-01-01 JAMES MULLIGAN 2019-06-05
003 2017-01-01 JAMES MULLIGAN 2018-04-04
003 2016-01-01 JAMES MULLIGAN 2017-07-07
003 2015-01-01 JAMES MULLIGAN 2016-05-19
003 2014-01-01 JAMES MULLIGAN 2015-06-04
003 2013-01-01 JAMES MULLIGAN 2014-04-10
003 2012-01-01 JAMES MULLIGAN 2013-04-30
003 2011-01-01 JAMES MULLIGAN 2012-06-25
003 2010-01-01 JAMES MULLIGAN 2011-05-27

Plan id#	Filing Submission Date	Name of Administrator	Date Administrator Signed
003	2024-01-01	MARYLOU FIGUERA
003	2023-01-01
003	2023-01-01	JAMES MULLIGAN
003	2021-01-01	JAMES MULLIGAN	2022-10-13
003	2020-01-01	JAMES MULLIGAN	2021-10-01
003	2019-01-01	JAMES MULLIGAN	2020-07-08
003	2018-01-01	JAMES MULLIGAN	2019-06-05
003	2017-01-01	JAMES MULLIGAN	2018-04-04
003	2016-01-01	JAMES MULLIGAN	2017-07-07
003	2015-01-01	JAMES MULLIGAN	2016-05-19
003	2014-01-01	JAMES MULLIGAN	2015-06-04
003	2013-01-01	JAMES MULLIGAN	2014-04-10
003	2012-01-01	JAMES MULLIGAN	2013-04-30
003	2011-01-01	JAMES MULLIGAN	2012-06-25
003	2010-01-01	JAMES MULLIGAN	2011-05-27

Plan Statistics for CENTROME, INC. D/B/A ADVANCED BIOTECH CASH BALANCE PENSION TRUST

401k plan membership statisitcs for CENTROME, INC. D/B/A ADVANCED BIOTECH CASH BALANCE PENSION TRUST

Measure Date Value
2023: CENTROME, INC. D/B/A ADVANCED BIOTECH CASH BALANCE PENSION TRUST 2023 401k membership
Total participants, beginning-of-year 2023-01-01 126
Total number of active participants reported on line 7a of the Form 5500 2023-01-01 118
Number of retired or separated participants receiving benefits 2023-01-01 0
Number of other retired or separated participants entitled to future benefits 2023-01-01 14
Total of all active and inactive participants 2023-01-01 132
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2023-01-01 0
Total participants 2023-01-01 132
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2023-01-01 0
2022: CENTROME, INC. D/B/A ADVANCED BIOTECH CASH BALANCE PENSION TRUST 2022 401k membership
Market value of plan assets 2022-12-31 7,242,658
Acturial value of plan assets 2022-12-31 7,242,658
Funding target for retired participants and beneficiaries receiving payment 2022-12-31 0
Number of terminated vested participants 2022-12-31 15
Fundng target for terminated vested participants 2022-12-31 33,005
Active participant vested funding target 2022-12-31 5,765,994
Number of active participants 2022-12-31 112
Total funding liabilities for active participants 2022-12-31 5,765,994
Total participant count 2022-12-31 127
Total funding target for all participants 2022-12-31 5,798,999
Balance at beginning of prior year after applicable adjustments 2022-12-31 6,589
Prefunding balance at beginning of prior year after applicable adjustments 2022-12-31 577,381
Carryover balanced portion elected for use to offset prior years funding requirement 2022-12-31 0
Prefunding balanced used to offset prior years funding requirement 2022-12-31 0
Amount remaining of carryover balance 2022-12-31 6,589
Amount remaining of prefunding balance 2022-12-31 577,381
Present value of excess contributions 2022-12-31 738,593
Total available prior years excess cotributions available at beginning of current plan year to add to prefunding balance 2022-12-31 738,593
Total available prior years excess cotributions added at beginning of current plan year to add to prefunding balance 2022-12-31 0
Reductions in caryover balances due to elections or deemed elections 2022-12-31 0
Reductions in prefunding balances due to elections or deemed elections 2022-12-31 0
Balance of carryovers at beginning of current year 2022-12-31 6,665
Balance of prefunding at beginning of current year 2022-12-31 584,079
Total employer contributions 2022-12-31 727,469
Total employee contributions 2022-12-31 0
Contributions allocated toward unpaid minimum require contributions from prior years 2022-12-31 0
Contributions made to avoid restrictions adjusted to valuation date 2022-12-31 0
Contributions allocated toward minimum required contributions for current year adjusted to valuation date 2022-12-31 676,214
Unpaid minimum required contributions for all prior years 2022-12-31 0
iDiscounted employer contributions allocated toward unpaid minimum required contributions from prior years 2022-12-31 0
Remaining amount of unpaid minimum required contributions 2022-12-31 0
Minimum required contributions for current year target normal cost 2022-12-31 598,878
Net shortfall amortization installment of oustanding balance 2022-12-31 0
Waiver amortization installment 2022-12-31 0
Total funding amount beforereflecting carryover/prefunding balances 2022-12-31 0
Additional cash requirement 2022-12-31 0
Contributions allocatedtoward minimum required contributions for current year 2022-12-31 676,214
Unpaid minimum required contributions for current year 2022-12-31 0
Unpaid minimum required contributions for all years 2022-12-31 0
2021: CENTROME, INC. D/B/A ADVANCED BIOTECH CASH BALANCE PENSION TRUST 2021 401k membership
Market value of plan assets 2021-12-31 6,504,017
Acturial value of plan assets 2021-12-31 6,504,017
Funding target for retired participants and beneficiaries receiving payment 2021-12-31 0
Number of terminated vested participants 2021-12-31 17
Fundng target for terminated vested participants 2021-12-31 31,470
Active participant vested funding target 2021-12-31 5,085,483
Number of active participants 2021-12-31 108
Total funding liabilities for active participants 2021-12-31 5,085,483
Total participant count 2021-12-31 125
Total funding target for all participants 2021-12-31 5,116,953
Balance at beginning of prior year after applicable adjustments 2021-12-31 6,417
Prefunding balance at beginning of prior year after applicable adjustments 2021-12-31 562,311
Carryover balanced portion elected for use to offset prior years funding requirement 2021-12-31 0
Prefunding balanced used to offset prior years funding requirement 2021-12-31 0
Amount remaining of carryover balance 2021-12-31 6,417
Amount remaining of prefunding balance 2021-12-31 562,311
Present value of excess contributions 2021-12-31 709,215
Total available prior years excess cotributions available at beginning of current plan year to add to prefunding balance 2021-12-31 709,215
Total available prior years excess cotributions added at beginning of current plan year to add to prefunding balance 2021-12-31 0
Reductions in caryover balances due to elections or deemed elections 2021-12-31 0
Reductions in prefunding balances due to elections or deemed elections 2021-12-31 0
Balance of carryovers at beginning of current year 2021-12-31 6,589
Balance of prefunding at beginning of current year 2021-12-31 577,381
Total employer contributions 2021-12-31 734,473
Total employee contributions 2021-12-31 0
Contributions allocated toward unpaid minimum require contributions from prior years 2021-12-31 0
Contributions made to avoid restrictions adjusted to valuation date 2021-12-31 0
Contributions allocated toward minimum required contributions for current year adjusted to valuation date 2021-12-31 738,593
Unpaid minimum required contributions for all prior years 2021-12-31 0
iDiscounted employer contributions allocated toward unpaid minimum required contributions from prior years 2021-12-31 0
Remaining amount of unpaid minimum required contributions 2021-12-31 0
Minimum required contributions for current year target normal cost 2021-12-31 600,584
Net shortfall amortization installment of oustanding balance 2021-12-31 0
Waiver amortization installment 2021-12-31 0
Waived amount of outstanding balance 2021-12-31 0
Total funding amount beforereflecting carryover/prefunding balances 2021-12-31 0
Carryover balance elected to use to offset funding requirement 2021-12-31 0
Prefunding balance elected to use to offset funding requirement 2021-12-31 0
Additional cash requirement 2021-12-31 0
Contributions allocatedtoward minimum required contributions for current year 2021-12-31 738,593
Unpaid minimum required contributions for current year 2021-12-31 0
Unpaid minimum required contributions for all years 2021-12-31 0
2020: CENTROME, INC. D/B/A ADVANCED BIOTECH CASH BALANCE PENSION TRUST 2020 401k membership
Market value of plan assets 2020-12-31 5,722,020
Acturial value of plan assets 2020-12-31 5,722,020
Funding target for retired participants and beneficiaries receiving payment 2020-12-31 0
Number of terminated vested participants 2020-12-31 9
Fundng target for terminated vested participants 2020-12-31 10,311
Active participant vested funding target 2020-12-31 3,721,962
Number of active participants 2020-12-31 109
Total funding liabilities for active participants 2020-12-31 3,721,962
Total participant count 2020-12-31 118
Total funding target for all participants 2020-12-31 3,732,273
Balance at beginning of prior year after applicable adjustments 2020-12-31 6,024
Prefunding balance at beginning of prior year after applicable adjustments 2020-12-31 527,843
Carryover balanced portion elected for use to offset prior years funding requirement 2020-12-31 0
Prefunding balanced used to offset prior years funding requirement 2020-12-31 0
Amount remaining of carryover balance 2020-12-31 6,024
Amount remaining of prefunding balance 2020-12-31 527,843
Present value of excess contributions 2020-12-31 623,963
Total available prior years excess cotributions available at beginning of current plan year to add to prefunding balance 2020-12-31 623,963
Total available prior years excess cotributions added at beginning of current plan year to add to prefunding balance 2020-12-31 0
Reductions in caryover balances due to elections or deemed elections 2020-12-31 0
Reductions in prefunding balances due to elections or deemed elections 2020-12-31 0
Balance of carryovers at beginning of current year 2020-12-31 6,417
Balance of prefunding at beginning of current year 2020-12-31 562,311
Total employer contributions 2020-12-31 709,760
Total employee contributions 2020-12-31 0
Contributions allocated toward unpaid minimum require contributions from prior years 2020-12-31 0
Contributions made to avoid restrictions adjusted to valuation date 2020-12-31 0
Contributions allocated toward minimum required contributions for current year adjusted to valuation date 2020-12-31 709,215
Unpaid minimum required contributions for all prior years 2020-12-31 0
iDiscounted employer contributions allocated toward unpaid minimum required contributions from prior years 2020-12-31 0
Remaining amount of unpaid minimum required contributions 2020-12-31 0
Minimum required contributions for current year target normal cost 2020-12-31 468,333
Net shortfall amortization installment of oustanding balance 2020-12-31 0
Waiver amortization installment 2020-12-31 0
Waived amount of outstanding balance 2020-12-31 0
Total funding amount beforereflecting carryover/prefunding balances 2020-12-31 0
Carryover balance elected to use to offset funding requirement 2020-12-31 0
Prefunding balance elected to use to offset funding requirement 2020-12-31 0
Additional cash requirement 2020-12-31 0
Contributions allocatedtoward minimum required contributions for current year 2020-12-31 709,215
Unpaid minimum required contributions for current year 2020-12-31 0
Unpaid minimum required contributions for all years 2020-12-31 0
2019: CENTROME, INC. D/B/A ADVANCED BIOTECH CASH BALANCE PENSION TRUST 2019 401k membership
Market value of plan assets 2019-12-31 5,016,147
Acturial value of plan assets 2019-12-31 5,016,147
Funding target for retired participants and beneficiaries receiving payment 2019-12-31 0
Number of terminated vested participants 2019-12-31 11
Fundng target for terminated vested participants 2019-12-31 50,932
Active participant vested funding target 2019-12-31 3,388,613
Number of active participants 2019-12-31 92
Total funding liabilities for active participants 2019-12-31 3,388,613
Total participant count 2019-12-31 103
Total funding target for all participants 2019-12-31 3,439,545
Balance at beginning of prior year after applicable adjustments 2019-12-31 5,864
Prefunding balance at beginning of prior year after applicable adjustments 2019-12-31 513,816
Carryover balanced portion elected for use to offset prior years funding requirement 2019-12-31 0
Prefunding balanced used to offset prior years funding requirement 2019-12-31 0
Amount remaining of carryover balance 2019-12-31 5,864
Amount remaining of prefunding balance 2019-12-31 513,816
Present value of excess contributions 2019-12-31 573,291
Total available prior years excess cotributions available at beginning of current plan year to add to prefunding balance 2019-12-31 573,291
Total available prior years excess cotributions added at beginning of current plan year to add to prefunding balance 2019-12-31 0
Reductions in caryover balances due to elections or deemed elections 2019-12-31 0
Reductions in prefunding balances due to elections or deemed elections 2019-12-31 0
Balance of carryovers at beginning of current year 2019-12-31 6,024
Balance of prefunding at beginning of current year 2019-12-31 527,843
Total employer contributions 2019-12-31 628,508
Total employee contributions 2019-12-31 0
Contributions allocated toward unpaid minimum require contributions from prior years 2019-12-31 0
Contributions made to avoid restrictions adjusted to valuation date 2019-12-31 0
Contributions allocated toward minimum required contributions for current year adjusted to valuation date 2019-12-31 623,963
Unpaid minimum required contributions for all prior years 2019-12-31 0
iDiscounted employer contributions allocated toward unpaid minimum required contributions from prior years 2019-12-31 0
Remaining amount of unpaid minimum required contributions 2019-12-31 0
Minimum required contributions for current year target normal cost 2019-12-31 477,251
Net shortfall amortization installment of oustanding balance 2019-12-31 0
Waiver amortization installment 2019-12-31 0
Waived amount of outstanding balance 2019-12-31 0
Total funding amount beforereflecting carryover/prefunding balances 2019-12-31 0
Carryover balance elected to use to offset funding requirement 2019-12-31 0
Prefunding balance elected to use to offset funding requirement 2019-12-31 0
Additional cash requirement 2019-12-31 0
Contributions allocatedtoward minimum required contributions for current year 2019-12-31 623,963
Unpaid minimum required contributions for current year 2019-12-31 0
Unpaid minimum required contributions for all years 2019-12-31 0
2018: CENTROME, INC. D/B/A ADVANCED BIOTECH CASH BALANCE PENSION TRUST 2018 401k membership
Market value of plan assets 2018-12-31 4,378,172
Acturial value of plan assets 2018-12-31 4,378,172
Funding target for retired participants and beneficiaries receiving payment 2018-12-31 0
Number of terminated vested participants 2018-12-31 9
Fundng target for terminated vested participants 2018-12-31 114,477
Active participant vested funding target 2018-12-31 2,718,286
Number of active participants 2018-12-31 77
Total funding liabilities for active participants 2018-12-31 2,718,286
Total participant count 2018-12-31 86
Total funding target for all participants 2018-12-31 2,832,763
Balance at beginning of prior year after applicable adjustments 2018-12-31 5,273
Prefunding balance at beginning of prior year after applicable adjustments 2018-12-31 462,023
Carryover balanced portion elected for use to offset prior years funding requirement 2018-12-31 0
Prefunding balanced used to offset prior years funding requirement 2018-12-31 0
Amount remaining of carryover balance 2018-12-31 5,273
Amount remaining of prefunding balance 2018-12-31 462,023
Present value of excess contributions 2018-12-31 545,650
Total available prior years excess cotributions available at beginning of current plan year to add to prefunding balance 2018-12-31 545,650
Total available prior years excess cotributions added at beginning of current plan year to add to prefunding balance 2018-12-31 0
Reductions in caryover balances due to elections or deemed elections 2018-12-31 0
Reductions in prefunding balances due to elections or deemed elections 2018-12-31 0
Balance of carryovers at beginning of current year 2018-12-31 5,864
Balance of prefunding at beginning of current year 2018-12-31 513,816
Total employer contributions 2018-12-31 578,791
Total employee contributions 2018-12-31 0
Contributions allocated toward unpaid minimum require contributions from prior years 2018-12-31 0
Contributions made to avoid restrictions adjusted to valuation date 2018-12-31 0
Contributions allocated toward minimum required contributions for current year adjusted to valuation date 2018-12-31 572,391
Unpaid minimum required contributions for all prior years 2018-12-31 0
iDiscounted employer contributions allocated toward unpaid minimum required contributions from prior years 2018-12-31 0
Remaining amount of unpaid minimum required contributions 2018-12-31 0
Minimum required contributions for current year target normal cost 2018-12-31 398,025
Net shortfall amortization installment of oustanding balance 2018-12-31 0
Waiver amortization installment 2018-12-31 0
Waived amount of outstanding balance 2018-12-31 0
Total funding amount beforereflecting carryover/prefunding balances 2018-12-31 0
Carryover balance elected to use to offset funding requirement 2018-12-31 0
Prefunding balance elected to use to offset funding requirement 2018-12-31 0
Additional cash requirement 2018-12-31 0
Contributions allocatedtoward minimum required contributions for current year 2018-12-31 572,391
Unpaid minimum required contributions for current year 2018-12-31 0
Unpaid minimum required contributions for all years 2018-12-31 0
2017: CENTROME, INC. D/B/A ADVANCED BIOTECH CASH BALANCE PENSION TRUST 2017 401k membership
Market value of plan assets 2017-12-31 3,716,812
Acturial value of plan assets 2017-12-31 3,716,812
Funding target for retired participants and beneficiaries receiving payment 2017-12-31 0
Number of terminated vested participants 2017-12-31 2
Fundng target for terminated vested participants 2017-12-31 19,028
Active participant vested funding target 2017-12-31 2,260,430
Number of active participants 2017-12-31 77
Total funding liabilities for active participants 2017-12-31 2,260,430
Total participant count 2017-12-31 79
Total funding target for all participants 2017-12-31 2,279,458
Balance at beginning of prior year after applicable adjustments 2017-12-31 5,027
Prefunding balance at beginning of prior year after applicable adjustments 2017-12-31 440,441
Carryover balanced portion elected for use to offset prior years funding requirement 2017-12-31 0
Prefunding balanced used to offset prior years funding requirement 2017-12-31 0
Amount remaining of carryover balance 2017-12-31 5,027
Amount remaining of prefunding balance 2017-12-31 440,441
Present value of excess contributions 2017-12-31 429,133
Total available prior years excess cotributions available at beginning of current plan year to add to prefunding balance 2017-12-31 429,133
Total available prior years excess cotributions added at beginning of current plan year to add to prefunding balance 2017-12-31 0
Reductions in caryover balances due to elections or deemed elections 2017-12-31 0
Reductions in prefunding balances due to elections or deemed elections 2017-12-31 0
Balance of carryovers at beginning of current year 2017-12-31 5,273
Balance of prefunding at beginning of current year 2017-12-31 462,023
Total employer contributions 2017-12-31 546,989
Total employee contributions 2017-12-31 0
Contributions allocated toward unpaid minimum require contributions from prior years 2017-12-31 0
Contributions made to avoid restrictions adjusted to valuation date 2017-12-31 0
Contributions allocated toward minimum required contributions for current year adjusted to valuation date 2017-12-31 545,650
Unpaid minimum required contributions for all prior years 2017-12-31 0
iDiscounted employer contributions allocated toward unpaid minimum required contributions from prior years 2017-12-31 0
Remaining amount of unpaid minimum required contributions 2017-12-31 0
Minimum required contributions for current year target normal cost 2017-12-31 373,860
Net shortfall amortization installment of oustanding balance 2017-12-31 0
Waiver amortization installment 2017-12-31 0
Waived amount of outstanding balance 2017-12-31 0
Total funding amount beforereflecting carryover/prefunding balances 2017-12-31 0
Carryover balance elected to use to offset funding requirement 2017-12-31 0
Prefunding balance elected to use to offset funding requirement 2017-12-31 0
Additional cash requirement 2017-12-31 0
Contributions allocatedtoward minimum required contributions for current year 2017-12-31 545,650
Unpaid minimum required contributions for current year 2017-12-31 0
Unpaid minimum required contributions for all years 2017-12-31 0
2016: CENTROME, INC. D/B/A ADVANCED BIOTECH CASH BALANCE PENSION TRUST 2016 401k membership
Market value of plan assets 2016-12-31 3,568,104
Acturial value of plan assets 2016-12-31 3,568,104
Funding target for retired participants and beneficiaries receiving payment 2016-12-31 0
Number of terminated vested participants 2016-12-31 6
Fundng target for terminated vested participants 2016-12-31 714,853
Active participant vested funding target 2016-12-31 1,904,642
Number of active participants 2016-12-31 64
Total funding liabilities for active participants 2016-12-31 1,904,642
Total participant count 2016-12-31 70
Total funding target for all participants 2016-12-31 2,619,495
Balance at beginning of prior year after applicable adjustments 2016-12-31 4,971
Prefunding balance at beginning of prior year after applicable adjustments 2016-12-31 435,520
Carryover balanced portion elected for use to offset prior years funding requirement 2016-12-31 0
Prefunding balanced used to offset prior years funding requirement 2016-12-31 0
Amount remaining of carryover balance 2016-12-31 4,971
Amount remaining of prefunding balance 2016-12-31 435,520
Present value of excess contributions 2016-12-31 406,072
Total available prior years excess cotributions available at beginning of current plan year to add to prefunding balance 2016-12-31 406,072
Total available prior years excess cotributions added at beginning of current plan year to add to prefunding balance 2016-12-31 0
Reductions in caryover balances due to elections or deemed elections 2016-12-31 0
Reductions in prefunding balances due to elections or deemed elections 2016-12-31 0
Balance of carryovers at beginning of current year 2016-12-31 5,027
Balance of prefunding at beginning of current year 2016-12-31 440,441
Total employer contributions 2016-12-31 430,499
Total employee contributions 2016-12-31 0
Contributions allocated toward unpaid minimum require contributions from prior years 2016-12-31 0
Contributions made to avoid restrictions adjusted to valuation date 2016-12-31 0
Contributions allocated toward minimum required contributions for current year adjusted to valuation date 2016-12-31 429,133
Unpaid minimum required contributions for all prior years 2016-12-31 0
iDiscounted employer contributions allocated toward unpaid minimum required contributions from prior years 2016-12-31 0
Remaining amount of unpaid minimum required contributions 2016-12-31 0
Minimum required contributions for current year target normal cost 2016-12-31 299,873
Net shortfall amortization installment of oustanding balance 2016-12-31 0
Waiver amortization installment 2016-12-31 0
Waived amount of outstanding balance 2016-12-31 0
Total funding amount beforereflecting carryover/prefunding balances 2016-12-31 0
Carryover balance elected to use to offset funding requirement 2016-12-31 0
Prefunding balance elected to use to offset funding requirement 2016-12-31 0
Additional cash requirement 2016-12-31 0
Contributions allocatedtoward minimum required contributions for current year 2016-12-31 429,133
Unpaid minimum required contributions for current year 2016-12-31 0
Unpaid minimum required contributions for all years 2016-12-31 0

Measure	Date	Value
2023: CENTROME, INC. D/B/A ADVANCED BIOTECH CASH BALANCE PENSION TRUST 2023 401k membership
Total participants, beginning-of-year	2023-01-01	126
Total number of active participants reported on line 7a of the Form 5500	2023-01-01	118
Number of retired or separated participants receiving benefits	2023-01-01	0
Number of other retired or separated participants entitled to future benefits	2023-01-01	14
Total of all active and inactive participants	2023-01-01	132
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2023-01-01	0
Total participants	2023-01-01	132
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2023-01-01	0
2022: CENTROME, INC. D/B/A ADVANCED BIOTECH CASH BALANCE PENSION TRUST 2022 401k membership
Market value of plan assets	2022-12-31	7,242,658
Acturial value of plan assets	2022-12-31	7,242,658
Funding target for retired participants and beneficiaries receiving payment	2022-12-31	0
Number of terminated vested participants	2022-12-31	15
Fundng target for terminated vested participants	2022-12-31	33,005
Active participant vested funding target	2022-12-31	5,765,994
Number of active participants	2022-12-31	112
Total funding liabilities for active participants	2022-12-31	5,765,994
Total participant count	2022-12-31	127
Total funding target for all participants	2022-12-31	5,798,999
Balance at beginning of prior year after applicable adjustments	2022-12-31	6,589
Prefunding balance at beginning of prior year after applicable adjustments	2022-12-31	577,381
Carryover balanced portion elected for use to offset prior years funding requirement	2022-12-31	0
Prefunding balanced used to offset prior years funding requirement	2022-12-31	0
Amount remaining of carryover balance	2022-12-31	6,589
Amount remaining of prefunding balance	2022-12-31	577,381
Present value of excess contributions	2022-12-31	738,593
Total available prior years excess cotributions available at beginning of current plan year to add to prefunding balance	2022-12-31	738,593
Total available prior years excess cotributions added at beginning of current plan year to add to prefunding balance	2022-12-31	0
Reductions in caryover balances due to elections or deemed elections	2022-12-31	0
Reductions in prefunding balances due to elections or deemed elections	2022-12-31	0
Balance of carryovers at beginning of current year	2022-12-31	6,665
Balance of prefunding at beginning of current year	2022-12-31	584,079
Total employer contributions	2022-12-31	727,469
Total employee contributions	2022-12-31	0
Contributions allocated toward unpaid minimum require contributions from prior years	2022-12-31	0
Contributions made to avoid restrictions adjusted to valuation date	2022-12-31	0
Contributions allocated toward minimum required contributions for current year adjusted to valuation date	2022-12-31	676,214
Unpaid minimum required contributions for all prior years	2022-12-31	0
iDiscounted employer contributions allocated toward unpaid minimum required contributions from prior years	2022-12-31	0
Remaining amount of unpaid minimum required contributions	2022-12-31	0
Minimum required contributions for current year target normal cost	2022-12-31	598,878
Net shortfall amortization installment of oustanding balance	2022-12-31	0
Waiver amortization installment	2022-12-31	0
Total funding amount beforereflecting carryover/prefunding balances	2022-12-31	0
Additional cash requirement	2022-12-31	0
Contributions allocatedtoward minimum required contributions for current year	2022-12-31	676,214
Unpaid minimum required contributions for current year	2022-12-31	0
Unpaid minimum required contributions for all years	2022-12-31	0
2021: CENTROME, INC. D/B/A ADVANCED BIOTECH CASH BALANCE PENSION TRUST 2021 401k membership
Market value of plan assets	2021-12-31	6,504,017
Acturial value of plan assets	2021-12-31	6,504,017
Funding target for retired participants and beneficiaries receiving payment	2021-12-31	0
Number of terminated vested participants	2021-12-31	17
Fundng target for terminated vested participants	2021-12-31	31,470
Active participant vested funding target	2021-12-31	5,085,483
Number of active participants	2021-12-31	108
Total funding liabilities for active participants	2021-12-31	5,085,483
Total participant count	2021-12-31	125
Total funding target for all participants	2021-12-31	5,116,953
Balance at beginning of prior year after applicable adjustments	2021-12-31	6,417
Prefunding balance at beginning of prior year after applicable adjustments	2021-12-31	562,311
Carryover balanced portion elected for use to offset prior years funding requirement	2021-12-31	0
Prefunding balanced used to offset prior years funding requirement	2021-12-31	0
Amount remaining of carryover balance	2021-12-31	6,417
Amount remaining of prefunding balance	2021-12-31	562,311
Present value of excess contributions	2021-12-31	709,215
Total available prior years excess cotributions available at beginning of current plan year to add to prefunding balance	2021-12-31	709,215
Total available prior years excess cotributions added at beginning of current plan year to add to prefunding balance	2021-12-31	0
Reductions in caryover balances due to elections or deemed elections	2021-12-31	0
Reductions in prefunding balances due to elections or deemed elections	2021-12-31	0
Balance of carryovers at beginning of current year	2021-12-31	6,589
Balance of prefunding at beginning of current year	2021-12-31	577,381
Total employer contributions	2021-12-31	734,473
Total employee contributions	2021-12-31	0
Contributions allocated toward unpaid minimum require contributions from prior years	2021-12-31	0
Contributions made to avoid restrictions adjusted to valuation date	2021-12-31	0
Contributions allocated toward minimum required contributions for current year adjusted to valuation date	2021-12-31	738,593
Unpaid minimum required contributions for all prior years	2021-12-31	0
iDiscounted employer contributions allocated toward unpaid minimum required contributions from prior years	2021-12-31	0
Remaining amount of unpaid minimum required contributions	2021-12-31	0
Minimum required contributions for current year target normal cost	2021-12-31	600,584
Net shortfall amortization installment of oustanding balance	2021-12-31	0
Waiver amortization installment	2021-12-31	0
Waived amount of outstanding balance	2021-12-31	0
Total funding amount beforereflecting carryover/prefunding balances	2021-12-31	0
Carryover balance elected to use to offset funding requirement	2021-12-31	0
Prefunding balance elected to use to offset funding requirement	2021-12-31	0
Additional cash requirement	2021-12-31	0
Contributions allocatedtoward minimum required contributions for current year	2021-12-31	738,593
Unpaid minimum required contributions for current year	2021-12-31	0
Unpaid minimum required contributions for all years	2021-12-31	0
2020: CENTROME, INC. D/B/A ADVANCED BIOTECH CASH BALANCE PENSION TRUST 2020 401k membership
Market value of plan assets	2020-12-31	5,722,020
Acturial value of plan assets	2020-12-31	5,722,020
Funding target for retired participants and beneficiaries receiving payment	2020-12-31	0
Number of terminated vested participants	2020-12-31	9
Fundng target for terminated vested participants	2020-12-31	10,311
Active participant vested funding target	2020-12-31	3,721,962
Number of active participants	2020-12-31	109
Total funding liabilities for active participants	2020-12-31	3,721,962
Total participant count	2020-12-31	118
Total funding target for all participants	2020-12-31	3,732,273
Balance at beginning of prior year after applicable adjustments	2020-12-31	6,024
Prefunding balance at beginning of prior year after applicable adjustments	2020-12-31	527,843
Carryover balanced portion elected for use to offset prior years funding requirement	2020-12-31	0
Prefunding balanced used to offset prior years funding requirement	2020-12-31	0
Amount remaining of carryover balance	2020-12-31	6,024
Amount remaining of prefunding balance	2020-12-31	527,843
Present value of excess contributions	2020-12-31	623,963
Total available prior years excess cotributions available at beginning of current plan year to add to prefunding balance	2020-12-31	623,963
Total available prior years excess cotributions added at beginning of current plan year to add to prefunding balance	2020-12-31	0
Reductions in caryover balances due to elections or deemed elections	2020-12-31	0
Reductions in prefunding balances due to elections or deemed elections	2020-12-31	0
Balance of carryovers at beginning of current year	2020-12-31	6,417
Balance of prefunding at beginning of current year	2020-12-31	562,311
Total employer contributions	2020-12-31	709,760
Total employee contributions	2020-12-31	0
Contributions allocated toward unpaid minimum require contributions from prior years	2020-12-31	0
Contributions made to avoid restrictions adjusted to valuation date	2020-12-31	0
Contributions allocated toward minimum required contributions for current year adjusted to valuation date	2020-12-31	709,215
Unpaid minimum required contributions for all prior years	2020-12-31	0
iDiscounted employer contributions allocated toward unpaid minimum required contributions from prior years	2020-12-31	0
Remaining amount of unpaid minimum required contributions	2020-12-31	0
Minimum required contributions for current year target normal cost	2020-12-31	468,333
Net shortfall amortization installment of oustanding balance	2020-12-31	0
Waiver amortization installment	2020-12-31	0
Waived amount of outstanding balance	2020-12-31	0
Total funding amount beforereflecting carryover/prefunding balances	2020-12-31	0
Carryover balance elected to use to offset funding requirement	2020-12-31	0
Prefunding balance elected to use to offset funding requirement	2020-12-31	0
Additional cash requirement	2020-12-31	0
Contributions allocatedtoward minimum required contributions for current year	2020-12-31	709,215
Unpaid minimum required contributions for current year	2020-12-31	0
Unpaid minimum required contributions for all years	2020-12-31	0
2019: CENTROME, INC. D/B/A ADVANCED BIOTECH CASH BALANCE PENSION TRUST 2019 401k membership
Market value of plan assets	2019-12-31	5,016,147
Acturial value of plan assets	2019-12-31	5,016,147
Funding target for retired participants and beneficiaries receiving payment	2019-12-31	0
Number of terminated vested participants	2019-12-31	11
Fundng target for terminated vested participants	2019-12-31	50,932
Active participant vested funding target	2019-12-31	3,388,613
Number of active participants	2019-12-31	92
Total funding liabilities for active participants	2019-12-31	3,388,613
Total participant count	2019-12-31	103
Total funding target for all participants	2019-12-31	3,439,545
Balance at beginning of prior year after applicable adjustments	2019-12-31	5,864
Prefunding balance at beginning of prior year after applicable adjustments	2019-12-31	513,816
Carryover balanced portion elected for use to offset prior years funding requirement	2019-12-31	0
Prefunding balanced used to offset prior years funding requirement	2019-12-31	0
Amount remaining of carryover balance	2019-12-31	5,864
Amount remaining of prefunding balance	2019-12-31	513,816
Present value of excess contributions	2019-12-31	573,291
Total available prior years excess cotributions available at beginning of current plan year to add to prefunding balance	2019-12-31	573,291
Total available prior years excess cotributions added at beginning of current plan year to add to prefunding balance	2019-12-31	0
Reductions in caryover balances due to elections or deemed elections	2019-12-31	0
Reductions in prefunding balances due to elections or deemed elections	2019-12-31	0
Balance of carryovers at beginning of current year	2019-12-31	6,024
Balance of prefunding at beginning of current year	2019-12-31	527,843
Total employer contributions	2019-12-31	628,508
Total employee contributions	2019-12-31	0
Contributions allocated toward unpaid minimum require contributions from prior years	2019-12-31	0
Contributions made to avoid restrictions adjusted to valuation date	2019-12-31	0
Contributions allocated toward minimum required contributions for current year adjusted to valuation date	2019-12-31	623,963
Unpaid minimum required contributions for all prior years	2019-12-31	0
iDiscounted employer contributions allocated toward unpaid minimum required contributions from prior years	2019-12-31	0
Remaining amount of unpaid minimum required contributions	2019-12-31	0
Minimum required contributions for current year target normal cost	2019-12-31	477,251
Net shortfall amortization installment of oustanding balance	2019-12-31	0
Waiver amortization installment	2019-12-31	0
Waived amount of outstanding balance	2019-12-31	0
Total funding amount beforereflecting carryover/prefunding balances	2019-12-31	0
Carryover balance elected to use to offset funding requirement	2019-12-31	0
Prefunding balance elected to use to offset funding requirement	2019-12-31	0
Additional cash requirement	2019-12-31	0
Contributions allocatedtoward minimum required contributions for current year	2019-12-31	623,963
Unpaid minimum required contributions for current year	2019-12-31	0
Unpaid minimum required contributions for all years	2019-12-31	0
2018: CENTROME, INC. D/B/A ADVANCED BIOTECH CASH BALANCE PENSION TRUST 2018 401k membership
Market value of plan assets	2018-12-31	4,378,172
Acturial value of plan assets	2018-12-31	4,378,172
Funding target for retired participants and beneficiaries receiving payment	2018-12-31	0
Number of terminated vested participants	2018-12-31	9
Fundng target for terminated vested participants	2018-12-31	114,477
Active participant vested funding target	2018-12-31	2,718,286
Number of active participants	2018-12-31	77
Total funding liabilities for active participants	2018-12-31	2,718,286
Total participant count	2018-12-31	86
Total funding target for all participants	2018-12-31	2,832,763
Balance at beginning of prior year after applicable adjustments	2018-12-31	5,273
Prefunding balance at beginning of prior year after applicable adjustments	2018-12-31	462,023
Carryover balanced portion elected for use to offset prior years funding requirement	2018-12-31	0
Prefunding balanced used to offset prior years funding requirement	2018-12-31	0
Amount remaining of carryover balance	2018-12-31	5,273
Amount remaining of prefunding balance	2018-12-31	462,023
Present value of excess contributions	2018-12-31	545,650
Total available prior years excess cotributions available at beginning of current plan year to add to prefunding balance	2018-12-31	545,650
Total available prior years excess cotributions added at beginning of current plan year to add to prefunding balance	2018-12-31	0
Reductions in caryover balances due to elections or deemed elections	2018-12-31	0
Reductions in prefunding balances due to elections or deemed elections	2018-12-31	0
Balance of carryovers at beginning of current year	2018-12-31	5,864
Balance of prefunding at beginning of current year	2018-12-31	513,816
Total employer contributions	2018-12-31	578,791
Total employee contributions	2018-12-31	0
Contributions allocated toward unpaid minimum require contributions from prior years	2018-12-31	0
Contributions made to avoid restrictions adjusted to valuation date	2018-12-31	0
Contributions allocated toward minimum required contributions for current year adjusted to valuation date	2018-12-31	572,391
Unpaid minimum required contributions for all prior years	2018-12-31	0
iDiscounted employer contributions allocated toward unpaid minimum required contributions from prior years	2018-12-31	0
Remaining amount of unpaid minimum required contributions	2018-12-31	0
Minimum required contributions for current year target normal cost	2018-12-31	398,025
Net shortfall amortization installment of oustanding balance	2018-12-31	0
Waiver amortization installment	2018-12-31	0
Waived amount of outstanding balance	2018-12-31	0
Total funding amount beforereflecting carryover/prefunding balances	2018-12-31	0
Carryover balance elected to use to offset funding requirement	2018-12-31	0
Prefunding balance elected to use to offset funding requirement	2018-12-31	0
Additional cash requirement	2018-12-31	0
Contributions allocatedtoward minimum required contributions for current year	2018-12-31	572,391
Unpaid minimum required contributions for current year	2018-12-31	0
Unpaid minimum required contributions for all years	2018-12-31	0
2017: CENTROME, INC. D/B/A ADVANCED BIOTECH CASH BALANCE PENSION TRUST 2017 401k membership
Market value of plan assets	2017-12-31	3,716,812
Acturial value of plan assets	2017-12-31	3,716,812
Funding target for retired participants and beneficiaries receiving payment	2017-12-31	0
Number of terminated vested participants	2017-12-31	2
Fundng target for terminated vested participants	2017-12-31	19,028
Active participant vested funding target	2017-12-31	2,260,430
Number of active participants	2017-12-31	77
Total funding liabilities for active participants	2017-12-31	2,260,430
Total participant count	2017-12-31	79
Total funding target for all participants	2017-12-31	2,279,458
Balance at beginning of prior year after applicable adjustments	2017-12-31	5,027
Prefunding balance at beginning of prior year after applicable adjustments	2017-12-31	440,441
Carryover balanced portion elected for use to offset prior years funding requirement	2017-12-31	0
Prefunding balanced used to offset prior years funding requirement	2017-12-31	0
Amount remaining of carryover balance	2017-12-31	5,027
Amount remaining of prefunding balance	2017-12-31	440,441
Present value of excess contributions	2017-12-31	429,133
Total available prior years excess cotributions available at beginning of current plan year to add to prefunding balance	2017-12-31	429,133
Total available prior years excess cotributions added at beginning of current plan year to add to prefunding balance	2017-12-31	0
Reductions in caryover balances due to elections or deemed elections	2017-12-31	0
Reductions in prefunding balances due to elections or deemed elections	2017-12-31	0
Balance of carryovers at beginning of current year	2017-12-31	5,273
Balance of prefunding at beginning of current year	2017-12-31	462,023
Total employer contributions	2017-12-31	546,989
Total employee contributions	2017-12-31	0
Contributions allocated toward unpaid minimum require contributions from prior years	2017-12-31	0
Contributions made to avoid restrictions adjusted to valuation date	2017-12-31	0
Contributions allocated toward minimum required contributions for current year adjusted to valuation date	2017-12-31	545,650
Unpaid minimum required contributions for all prior years	2017-12-31	0
iDiscounted employer contributions allocated toward unpaid minimum required contributions from prior years	2017-12-31	0
Remaining amount of unpaid minimum required contributions	2017-12-31	0
Minimum required contributions for current year target normal cost	2017-12-31	373,860
Net shortfall amortization installment of oustanding balance	2017-12-31	0
Waiver amortization installment	2017-12-31	0
Waived amount of outstanding balance	2017-12-31	0
Total funding amount beforereflecting carryover/prefunding balances	2017-12-31	0
Carryover balance elected to use to offset funding requirement	2017-12-31	0
Prefunding balance elected to use to offset funding requirement	2017-12-31	0
Additional cash requirement	2017-12-31	0
Contributions allocatedtoward minimum required contributions for current year	2017-12-31	545,650
Unpaid minimum required contributions for current year	2017-12-31	0
Unpaid minimum required contributions for all years	2017-12-31	0
2016: CENTROME, INC. D/B/A ADVANCED BIOTECH CASH BALANCE PENSION TRUST 2016 401k membership
Market value of plan assets	2016-12-31	3,568,104
Acturial value of plan assets	2016-12-31	3,568,104
Funding target for retired participants and beneficiaries receiving payment	2016-12-31	0
Number of terminated vested participants	2016-12-31	6
Fundng target for terminated vested participants	2016-12-31	714,853
Active participant vested funding target	2016-12-31	1,904,642
Number of active participants	2016-12-31	64
Total funding liabilities for active participants	2016-12-31	1,904,642
Total participant count	2016-12-31	70
Total funding target for all participants	2016-12-31	2,619,495
Balance at beginning of prior year after applicable adjustments	2016-12-31	4,971
Prefunding balance at beginning of prior year after applicable adjustments	2016-12-31	435,520
Carryover balanced portion elected for use to offset prior years funding requirement	2016-12-31	0
Prefunding balanced used to offset prior years funding requirement	2016-12-31	0
Amount remaining of carryover balance	2016-12-31	4,971
Amount remaining of prefunding balance	2016-12-31	435,520
Present value of excess contributions	2016-12-31	406,072
Total available prior years excess cotributions available at beginning of current plan year to add to prefunding balance	2016-12-31	406,072
Total available prior years excess cotributions added at beginning of current plan year to add to prefunding balance	2016-12-31	0
Reductions in caryover balances due to elections or deemed elections	2016-12-31	0
Reductions in prefunding balances due to elections or deemed elections	2016-12-31	0
Balance of carryovers at beginning of current year	2016-12-31	5,027
Balance of prefunding at beginning of current year	2016-12-31	440,441
Total employer contributions	2016-12-31	430,499
Total employee contributions	2016-12-31	0
Contributions allocated toward unpaid minimum require contributions from prior years	2016-12-31	0
Contributions made to avoid restrictions adjusted to valuation date	2016-12-31	0
Contributions allocated toward minimum required contributions for current year adjusted to valuation date	2016-12-31	429,133
Unpaid minimum required contributions for all prior years	2016-12-31	0
iDiscounted employer contributions allocated toward unpaid minimum required contributions from prior years	2016-12-31	0
Remaining amount of unpaid minimum required contributions	2016-12-31	0
Minimum required contributions for current year target normal cost	2016-12-31	299,873
Net shortfall amortization installment of oustanding balance	2016-12-31	0
Waiver amortization installment	2016-12-31	0
Waived amount of outstanding balance	2016-12-31	0
Total funding amount beforereflecting carryover/prefunding balances	2016-12-31	0
Carryover balance elected to use to offset funding requirement	2016-12-31	0
Prefunding balance elected to use to offset funding requirement	2016-12-31	0
Additional cash requirement	2016-12-31	0
Contributions allocatedtoward minimum required contributions for current year	2016-12-31	429,133
Unpaid minimum required contributions for current year	2016-12-31	0
Unpaid minimum required contributions for all years	2016-12-31	0

Financial Data on CENTROME, INC. D/B/A ADVANCED BIOTECH CASH BALANCE PENSION TRUST

Measure	Date	Value
2023 : CENTROME, INC. D/B/A ADVANCED BIOTECH CASH BALANCE PENSION TRUST 2023 401k financial data
Unrealized appreciation/depreciation of real estate assets	2023-12-31	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2023-12-31	$0
Total unrealized appreciation/depreciation of assets	2023-12-31	$0
Total transfer of assets to this plan	2023-12-31	$0
Total transfer of assets from this plan	2023-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2023-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2023-12-31	$0
Expenses. Interest paid	2023-12-31	$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102	2023-12-31	$0
Total income from all sources (including contributions)	2023-12-31	$1,094,014
Total loss/gain on sale of assets	2023-12-31	$0
Total of all expenses incurred	2023-12-31	$181,327
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2023-12-31	$181,327
Expenses. Certain deemed distributions of participant loans	2023-12-31	$0
Value of total corrective distributions	2023-12-31	$0
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2023-12-31	$772,840
Value of total assets at end of year	2023-12-31	$7,159,402
Value of total assets at beginning of year	2023-12-31	$6,246,715
Total of administrative expenses incurred including professional, contract, advisory and management fees	2023-12-31	$0
Total income from rents	2023-12-31	$0
Total interest from all sources	2023-12-31	$0
Total dividends received (eg from common stock, registered investment company shares)	2023-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2023-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2023-12-31	$0
Assets. Real estate other than employer real property at end of year	2023-12-31	$0
Assets. Real estate other than employer real property at beginning of year	2023-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at end of year	2023-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2023-12-31	$0
Was this plan covered by a fidelity bond	2023-12-31	Yes
Value of fidelity bond cover	2023-12-31	$500,000
Were there any nonexempt tranactions with any party-in-interest	2023-12-31	No
Contributions received from participants	2023-12-31	$0
Participant contributions at end of year	2023-12-31	$0
Participant contributions at beginning of year	2023-12-31	$0
Participant contributions at end of year	2023-12-31	$0
Participant contributions at beginning of year	2023-12-31	$0
Assets. Other investments not covered elsewhere at end of year	2023-12-31	$0
Assets. Other investments not covered elsewhere at beginning of year	2023-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2023-12-31	$0
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2023-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at end of year	2023-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2023-12-31	$0
Assets. Loans (other than to participants) at end of year	2023-12-31	$0
Assets. Loans (other than to participants) at beginning of year	2023-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2023-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2023-12-31	$0
Other income not declared elsewhere	2023-12-31	$0
Administrative expenses (other) incurred	2023-12-31	$0
Liabilities. Value of operating payables at end of year	2023-12-31	$0
Liabilities. Value of operating payables at beginning of year	2023-12-31	$0
Total non interest bearing cash at end of year	2023-12-31	$0
Total non interest bearing cash at beginning of year	2023-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2023-12-31	No
Income. Non cash contributions	2023-12-31	$0
Value of net income/loss	2023-12-31	$912,687
Value of net assets at end of year (total assets less liabilities)	2023-12-31	$7,159,402
Value of net assets at beginning of year (total assets less liabilities)	2023-12-31	$6,246,715
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2023-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2023-12-31	No
Were any leases to which the plan was party in default or uncollectible	2023-12-31	No
Assets. partnership/joint venture interests at end of year	2023-12-31	$0
Assets. partnership/joint venture interests at beginning of year	2023-12-31	$0
Investment advisory and management fees	2023-12-31	$0
Value of interest in registered invesment companies (eg mutual funds) at end of year	2023-12-31	$6,736,562
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2023-12-31	$5,519,246
Value of interest in pooled separate accounts at end of year	2023-12-31	$0
Value of interest in pooled separate accounts at beginning of year	2023-12-31	$0
Interest on participant loans	2023-12-31	$0
Income. Interest from loans (other than to participants)	2023-12-31	$0
Interest earned on other investments	2023-12-31	$0
Income. Interest from US Government securities	2023-12-31	$0
Income. Interest from corporate debt instruments	2023-12-31	$0
Value of interest in master investment trust accounts at end of year	2023-12-31	$0
Value of interest in master investment trust accounts at beginning of year	2023-12-31	$0
Value of interest in common/collective trusts at end of year	2023-12-31	$0
Value of interest in common/collective trusts at beginning of year	2023-12-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2023-12-31	$0
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2023-12-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2023-12-31	$0
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2023-12-31	$0
Assets. Value of investments in 103.12 investment entities at end of year	2023-12-31	$0
Assets. Value of investments in 103.12 investment entities at beginning of year	2023-12-31	$0
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2023-12-31	$0
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2023-12-31	$0
Expenses. Payments to insurance carriers foe the provision of benefits	2023-12-31	$0
Asset value of US Government securities at end of year	2023-12-31	$0
Asset value of US Government securities at beginning of year	2023-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2023-12-31	$0
Net investment gain/loss from pooled separate accounts	2023-12-31	$321,174
Net investment gain or loss from common/collective trusts	2023-12-31	$0
Net gain/loss from 103.12 investment entities	2023-12-31	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2023-12-31	No
Was there a failure to transmit to the plan any participant contributions	2023-12-31	No
Has the plan failed to provide any benefit when due under the plan	2023-12-31	No
Assets. Invements in employer securities at end of year	2023-12-31	$0
Assets. Invements in employer securities at beginning of year	2023-12-31	$0
Assets. Value of employer real property at end of year	2023-12-31	$0
Assets. Value of employer real property at beginning of year	2023-12-31	$0
Contributions received in cash from employer	2023-12-31	$772,840
Employer contributions (assets) at end of year	2023-12-31	$422,840
Employer contributions (assets) at beginning of year	2023-12-31	$727,469
Income. Dividends from preferred stock	2023-12-31	$0
Income. Dividends from common stock	2023-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2023-12-31	$181,327
Asset. Corporate debt instrument preferred debt at end of year	2023-12-31	$0
Asset. Corporate debt instrument preferred debt at beginning of year	2023-12-31	$0
Asset. Corporate debt instrument debt (other) at end of year	2023-12-31	$0
Asset. Corporate debt instrument debt (other) at beginning of year	2023-12-31	$0
Contract administrator fees	2023-12-31	$0
Assets. Corporate common stocks other than exployer securities at end of year	2023-12-31	$0
Assets. Corporate common stocks other than exployer securities at beginning of year	2023-12-31	$0
Liabilities. Value of benefit claims payable at end of year	2023-12-31	$0
Liabilities. Value of benefit claims payable at beginning of year	2023-12-31	$0
Assets. Value of buildings and other operty used in plan operation at end of year	2023-12-31	$0
Assets. Value of buildings and other operty used in plan operation at beginning of year	2023-12-31	$0
Did the plan have assets held for investment	2023-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2023-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2023-12-31	No
Aggregate proceeds on sale of assets	2023-12-31	$0
Aggregate carrying amount (costs) on sale of assets	2023-12-31	$0
Liabilities. Value of acquisition indebtedness at end of year	2023-12-31	$0
Liabilities. Value of acquisition indebtedness at beginning of year	2023-12-31	$0
Opinion of an independent qualified public accountant for this plan	2023-12-31	Unqualified
Accountancy firm name	2023-12-31	MARCUM, LLP
Accountancy firm EIN	2023-12-31	111986323
Unrealized appreciation/depreciation of real estate assets	2023-01-01	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2023-01-01	$0
Total unrealized appreciation/depreciation of assets	2023-01-01	$0
Total transfer of assets to this plan	2023-01-01	$0
Total transfer of assets from this plan	2023-01-01	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2023-01-01	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2023-01-01	$0
Total income from all sources (including contributions)	2023-01-01	$1,094,014
Total loss/gain on sale of assets	2023-01-01	$0
Total of all expenses incurred	2023-01-01	$181,327
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2023-01-01	$181,327
Expenses. Certain deemed distributions of participant loans	2023-01-01	$0
Value of total corrective distributions	2023-01-01	$0
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2023-01-01	$772,840
Value of total assets at end of year	2023-01-01	$7,159,402
Value of total assets at beginning of year	2023-01-01	$6,246,715
Total of administrative expenses incurred including professional, contract, advisory and management fees	2023-01-01	$0
Total income from rents	2023-01-01	$0
Total interest from all sources	2023-01-01	$0
Total dividends received (eg from common stock, registered investment company shares)	2023-01-01	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2023-01-01	No
Total dividends received from registered investment company shares (eg mutual funds)	2023-01-01	$0
Assets. Real estate other than employer real property at end of year	2023-01-01	$0
Assets. Real estate other than employer real property at beginning of year	2023-01-01	$0
Assets. Corporate prefeered stocks other than exployer securities at end of year	2023-01-01	$0
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2023-01-01	$0
Was this plan covered by a fidelity bond	2023-01-01	Yes
Value of fidelity bond cover	2023-01-01	$500,000
Were there any nonexempt tranactions with any party-in-interest	2023-01-01	No
Contributions received from participants	2023-01-01	$0
Participant contributions at end of year	2023-01-01	$0
Participant contributions at beginning of year	2023-01-01	$0
Participant contributions at end of year	2023-01-01	$0
Participant contributions at beginning of year	2023-01-01	$0
Assets. Other investments not covered elsewhere at end of year	2023-01-01	$0
Assets. Other investments not covered elsewhere at beginning of year	2023-01-01	$0
Income. Received or receivable in cash from other sources (including rollovers)	2023-01-01	$0
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2023-01-01	$0
Value of other receiveables (less allowance for doubtful accounts) at end of year	2023-01-01	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2023-01-01	$0
Assets. Loans (other than to participants) at end of year	2023-01-01	$0
Assets. Loans (other than to participants) at beginning of year	2023-01-01	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2023-01-01	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2023-01-01	$0
Other income not declared elsewhere	2023-01-01	$0
Administrative expenses (other) incurred	2023-01-01	$0
Liabilities. Value of operating payables at end of year	2023-01-01	$0
Liabilities. Value of operating payables at beginning of year	2023-01-01	$0
Total non interest bearing cash at end of year	2023-01-01	$0
Total non interest bearing cash at beginning of year	2023-01-01	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2023-01-01	No
Income. Non cash contributions	2023-01-01	$0
Value of net income/loss	2023-01-01	$912,687
Value of net assets at end of year (total assets less liabilities)	2023-01-01	$7,159,402
Value of net assets at beginning of year (total assets less liabilities)	2023-01-01	$6,246,715
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2023-01-01	No
Were any loans by the plan or fixed income obligations due to the plan in default	2023-01-01	No
Were any leases to which the plan was party in default or uncollectible	2023-01-01	No
Assets. partnership/joint venture interests at end of year	2023-01-01	$0
Assets. partnership/joint venture interests at beginning of year	2023-01-01	$0
Investment advisory and management fees	2023-01-01	$0
Value of interest in registered invesment companies (eg mutual funds) at end of year	2023-01-01	$6,736,562
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2023-01-01	$5,519,246
Value of interest in pooled separate accounts at end of year	2023-01-01	$0
Value of interest in pooled separate accounts at beginning of year	2023-01-01	$0
Interest on participant loans	2023-01-01	$0
Income. Interest from loans (other than to participants)	2023-01-01	$0
Interest earned on other investments	2023-01-01	$0
Income. Interest from US Government securities	2023-01-01	$0
Income. Interest from corporate debt instruments	2023-01-01	$0
Value of interest in master investment trust accounts at end of year	2023-01-01	$0
Value of interest in master investment trust accounts at beginning of year	2023-01-01	$0
Value of interest in common/collective trusts at end of year	2023-01-01	$0
Value of interest in common/collective trusts at beginning of year	2023-01-01	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2023-01-01	$0
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2023-01-01	$0
Assets. Value of investments in 103.12 investment entities at end of year	2023-01-01	$0
Assets. Value of investments in 103.12 investment entities at beginning of year	2023-01-01	$0
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2023-01-01	$0
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2023-01-01	$0
Expenses. Payments to insurance carriers foe the provision of benefits	2023-01-01	$0
Asset value of US Government securities at end of year	2023-01-01	$0
Asset value of US Government securities at beginning of year	2023-01-01	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2023-01-01	$0
Net investment gain/loss from pooled separate accounts	2023-01-01	$321,174
Net investment gain or loss from common/collective trusts	2023-01-01	$0
Net gain/loss from 103.12 investment entities	2023-01-01	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2023-01-01	No
Was there a failure to transmit to the plan any participant contributions	2023-01-01	No
Has the plan failed to provide any benefit when due under the plan	2023-01-01	No
Assets. Invements in employer securities at end of year	2023-01-01	$0
Assets. Invements in employer securities at beginning of year	2023-01-01	$0
Assets. Value of employer real property at end of year	2023-01-01	$0
Assets. Value of employer real property at beginning of year	2023-01-01	$0
Contributions received in cash from employer	2023-01-01	$772,840
Employer contributions (assets) at end of year	2023-01-01	$422,840
Employer contributions (assets) at beginning of year	2023-01-01	$727,469
Income. Dividends from preferred stock	2023-01-01	$0
Income. Dividends from common stock	2023-01-01	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2023-01-01	$181,327
Asset. Corporate debt instrument preferred debt at end of year	2023-01-01	$0
Asset. Corporate debt instrument preferred debt at beginning of year	2023-01-01	$0
Asset. Corporate debt instrument debt (other) at end of year	2023-01-01	$0
Asset. Corporate debt instrument debt (other) at beginning of year	2023-01-01	$0
Contract administrator fees	2023-01-01	$0
Assets. Corporate common stocks other than exployer securities at end of year	2023-01-01	$0
Assets. Corporate common stocks other than exployer securities at beginning of year	2023-01-01	$0
Liabilities. Value of benefit claims payable at end of year	2023-01-01	$0
Liabilities. Value of benefit claims payable at beginning of year	2023-01-01	$0
Assets. Value of buildings and other operty used in plan operation at end of year	2023-01-01	$0
Assets. Value of buildings and other operty used in plan operation at beginning of year	2023-01-01	$0
Did the plan have assets held for investment	2023-01-01	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2023-01-01	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2023-01-01	No
Aggregate proceeds on sale of assets	2023-01-01	$0
Aggregate carrying amount (costs) on sale of assets	2023-01-01	$0
Liabilities. Value of acquisition indebtedness at end of year	2023-01-01	$0
Liabilities. Value of acquisition indebtedness at beginning of year	2023-01-01	$0
Opinion of an independent qualified public accountant for this plan	2023-01-01	1
Accountancy firm name	2023-01-01	MARCUM, LLP
Accountancy firm EIN	2023-01-01	111986323
2022 : CENTROME, INC. D/B/A ADVANCED BIOTECH CASH BALANCE PENSION TRUST 2022 401k financial data
Total income from all sources (including contributions)	2022-01-01	$637,027
Total of all expenses incurred	2022-01-01	$1,638,643
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2022-01-01	$1,638,643
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2022-01-01	$727,469
Value of total assets at end of year	2022-01-01	$6,246,715
Value of total assets at beginning of year	2022-01-01	$7,248,331
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2022-01-01	No
Was this plan covered by a fidelity bond	2022-01-01	Yes
Value of fidelity bond cover	2022-01-01	$500,000
If this is an individual account plan, was there a blackout period	2022-01-01	No
Were there any nonexempt tranactions with any party-in-interest	2022-01-01	No
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-01-01	No
Value of net income/loss	2022-01-01	$-1,001,616
Value of net assets at end of year (total assets less liabilities)	2022-01-01	$6,246,715
Value of net assets at beginning of year (total assets less liabilities)	2022-01-01	$7,248,331
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2022-01-01	No
Were any loans by the plan or fixed income obligations due to the plan in default	2022-01-01	No
Were any leases to which the plan was party in default or uncollectible	2022-01-01	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2022-01-01	$5,519,246
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2022-01-01	$6,913,858
Value of interest in master investment trust accounts at end of year	2022-01-01	$0
Value of interest in master investment trust accounts at beginning of year	2022-01-01	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2022-01-01	No
Was there a failure to transmit to the plan any participant contributions	2022-01-01	No
Has the plan failed to provide any benefit when due under the plan	2022-01-01	No
Contributions received in cash from employer	2022-01-01	$727,469
Employer contributions (assets) at end of year	2022-01-01	$727,469
Employer contributions (assets) at beginning of year	2022-01-01	$334,473
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2022-01-01	$1,638,643
Did the plan have assets held for investment	2022-01-01	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-01-01	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2022-01-01	No
Opinion of an independent qualified public accountant for this plan	2022-01-01	1
Accountancy firm name	2022-01-01	MARCUM, LLP
Accountancy firm EIN	2022-01-01	111986323

Form 5500 Responses for CENTROME, INC. D/B/A ADVANCED BIOTECH CASH BALANCE PENSION TRUST

2023: CENTROME, INC. D/B/A ADVANCED BIOTECH CASH BALANCE PENSION TRUST 2023 form 5500 responses
2023-01-01	Type of plan entity	Single employer plan
2023-01-01	Plan funding arrangement – Trust	Yes
2023-01-01	Plan benefit arrangement - Trust	Yes

Insurance Providers Used on plan

PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )

Policy contract number

626384

Policy instance

Insurance contract or identification number	626384
Number of Individuals Covered	129
Insurance policy start date	2023-01-01
Insurance policy end date	2023-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $2,981
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	CENTROME, INC. D/B/A ADVANCED BIOTECH
Employer identification number (EIN):	223253350
NAIC Classification:	423990
NAIC Description:	Other Miscellaneous Durable Goods Merchant Wholesalers